Evidence map›Paper›PMID 39499861›Full record

ArticleAmerican journal of respiratory cell and molecular biology2025

Precision-Cut Lung Slices: Emerging Tools for Preclinical and Translational Lung Research: An Official American Thoracic Society Workshop Report.

Mareike Lehmann, Ramaswamy Krishnan, Jennifer Sucre, Hrishikesh S Kulkarni, Ricardo H Pineda, Christopher Anderson, Nicholas E Banovich, Holger P Behrsing, Charlotte H Dean, Andrew Haak and 24 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Investigating human lung resilience, its evolutionary history and its relation to COPD.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Cellular plasticity and regenerative mechanisms in the lung.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  18. Endothelial Heterogeneity in Pulmonary Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Ramaswamy KrishnanORCID 0000-0003-4994-0709
Jennifer Sucre
Hrishikesh S KulkarniORCID 0000-0003-4830-5084
Ricardo H Pineda
Christopher Anderson
Nicholas E Banovich
Holger P BehrsingORCID 0000-0001-7284-9837
Andrew Haak
Reinoud Gosens
Cynthia Koziol-White
Jordan P Metcalf
Claudia Loebel
Enid Neptune
Alexandra Noel
Ganesh Raghu
Katherina Sewald
Ashish Sharma
Anne Sperling
Scott Turner
Pam Van Ry
Mauricio Rojas
Melanie KönigshoffORCID 0000-0001-9414-5128

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Sally W Thurston · 1985 to 2026
$42.8M
TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase IIIU01HL148861 · NHLBI · UNIVERSITY OF ROCHESTER · PI GLORIA S PRYHUBER · 2019 to 2026
$9.7M
The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung)U54HL165443 · NHLBI · UNIVERSITY OF ROCHESTER · PI PRYHUBER, GLORIA S · 2022 to 2025
$8.0M
Integrated Molecular and Cellular Drivers of AlveologenesisR01HL168556 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jennifer MalcolmSrygley Sucre · 2023 to 2026
$2.8M
Unraveling the molecular origins of chronic parenchymal lung diseasesU01HL175444 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Nicholas Eli Banovich, Jonathan Andrew Kropski · 2024 to 2026
$2.8M
mTORC1 and WNT in lung mesenchymeR01HL158737 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KRYMSKAYA, VERA P · 2021 to 2024
$2.5M
Non-canonical WNT signaling in emphysema and lung regenerationR01HL141380 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOENIGSHOFF, MELANIE · 2019 to 2022
$2.1M
Targeting Senescence Specific Mechanisms of NF-κB Activation to Reverse Chronic Pulmonary FibrosisR01HL167796 · NHLBI · MAYO CLINIC ROCHESTER · PI Andrew Jon Haak · 2024 to 2026
$1.7M
Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary FibrosisR61HL161804 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HAAK, ANDREW JON, HEYNEN-GENEL, SUSANNE · 2022 to 2023
$1.3M
Wnt Signaling in Bronchopulmonary DysplasiaK08HL143051 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SUCRE, JENNIFER MALCOLMSRYGLEY · 2019 to 2023
$698k
Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary FibrosisR33HL161804 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HAAK, ANDREW JON, HEYNEN-GENEL, SUSANNE · 2024 to 2024
$596k
BLRD VA I01 BX005023NHLBI NIH HHS K08 HL143051NHLBI NIH HHS R01 HL141380NHLBI NIH HHS R01 HL158737NHLBI NIH HHS R01 HL167796NHLBI NIH HHS R01 HL168556NHLBI NIH HHS U01 HL148861NHLBI NIH HHS U01 HL175444NHLBI NIH HHS U54 HL165443NIA NIH HHS U54 AG075931NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

The urgent need for effective treatments for acute and chronic lung diseases underscores the significance of developing innovative preclinical human research tools. The 2023 American Thoracic Society Workshop on Precision-Cut Lung Slices (PCLSs) brought together 35 experts to discuss and address the role of human tissue-derived PCLSs as a unique tool for target and drug discovery and validation in pulmonary medicine. With increasing interest and usage, together with advancements in methods and technology, there is a growing need for consensus on PCLS methodology and readouts. The current document recommends standard reporting criteria and emphasizes the requirement for careful collection and integration of clinical metadata. We further discuss current clinically relevant readouts that can be applied to PCLSs and highlight recent developments and future steps for implementing novel technologies for PCLS modeling and analysis. The collection and correlation of clinical metadata and multiomic analysis will further advance the integration of this preclinical platform into patient endotyping and the development of tailored therapies for patients with lung disease.

Indexed as

LungLung DiseasesTranslational Research, BiomedicalAnimalsHumansSocieties, MedicalUnited Statesbiomarkershuman ex vivo modelprecision-cut lung slicepreclinical researchtranslational research

Identifiers

PMID39499861
PMCPMC11707673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.